Lv3
326 积分 2022-11-03 加入
Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
7天前
已完结
Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies
14天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
28天前
已完结
Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial
28天前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
1个月前
已完结
Association between pathologic response and survival after neoadjuvant therapy in lung cancer
1个月前
已完结
Association of Recurrence with a Tumor-informed Personalized ctDNA Detection Approach in Resectable Colorectal Cancer: Results of a Prospective Observational Study
1个月前
已完结
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2
1个月前
已完结
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease
1个月前
已完结
皖公网安备34019202002308
